ADAM VOGEL to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications ADAM VOGEL has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.201
-
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER). Ann Oncol. 2020 02; 31(2):228-235.
Score: 0.095
-
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 10 01; 29(Suppl 4):iv238-iv255.
Score: 0.087
-
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. Ann Oncol. 2016 07; 27(7):1273-9.
Score: 0.018